Publication Summary
Cathepsin S, a new pruritus biomarker in clinical dandruff/ seborrhoeic dermatitis evaluation
Objective
Evaluation of the role of cathepsin S in pruritus associated with seborrheic dermatitis.
Cathepsin S is a cysteine protease that activates PAR-2 (proteinase-activated receptor 2) receptors
Methodology
N= 11 adult patients with seborrheic dermatitis of the scalp, compared with a control group (n=10)
Assessment of PAR2 and histamine protein expression to compare the results of two distinct pruritus-inducing pathways
Evaluation criteria
Global clinical score for severity of seborrheic dermatitis scored by the investigator (Squire score from 0 to 80)
Intensity of pruritus scored by patients (4-point scale)
Results
- Cathepsin S levels in patients with seborrheic dermatitis 5 times higher than in the control group
- Positive correlation between cathepsin S levels, PAR-2 receptor expression and pruritus intensity
Conclusion
Cathepsin S can be used as a biomarker to quantify pruritus sensations and contribute to the quantitative evaluation of the efficacy of seborrheic dermatitis treatments
Our other publications on this subject
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.
